Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Paul Koller et al.|Blood|2022Cited by 51
Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve SettingsJacqueline S. Garcia, Robert J. Soiffer, Yael Flamand et al.|Blood|2020Cited by 12
Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III studyGuillermo Garcia‐Manero, Lionel Adès, Maciej Kaźmierczak et al.|Leukemia Research|2024Cited by 12